Advanced Tissue Sciences' (US) engineered skin to get expedited review:
This article was originally published in Clinica
The US FDA has notified Advanced Tissue Sciences (US) that its premarket approval application for Dermagraft-Transitional Covering treatment for severe burns will receive expedited review. The company plans to submit a PMA by the end of the year on completion of a 65-patient trial. Dermagraft-TC comprises processed human dermis and a synthetic epidermis.